Sep 09, 2020 / 04:00PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon and good morning. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to our 2020 Virtual Health Care Conference. With us, we have the management team from Tandem Diabetes, John Sheridan, the CEO; and Leigh Vosseller, the CFO. The format is going to be fireside chat for 30 minutes. We're going to try to get one audience poll question in here. So John and Leigh, thanks so much for joining us.
John F. Sheridan - Tandem Diabetes Care, Inc. - President, CEO & Director
Thanks for having us, Larry.
Leigh A. Vosseller - Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer
Thank you.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystGreat. So I wanted to start at a high level. First, with the strategy. And